Tada T, Kumada T, Hiraoka A, Hirooka M, et al. Impact of first-line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2023 May 25. doi: 10.1111/jgh.16225.
PMID: 37231943